alpha-methylserotonin and vabicaserin

alpha-methylserotonin has been researched along with vabicaserin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett, JE; Coupet, J; Dunlop, J; Harrison, B; Mazandarani, H; Nawoschik, S; Pangalos, MN; Ramamoorthy, S; Rosenzweig-Lipson, S; Schechter, L; Smith, D; Stack, G; Watts, SW; Zhang, G; Zhang, J	1

Other Studies

1 other study(ies) available for alpha-methylserotonin and vabicaserin

Article	Year
Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:3 Topics: Animals; Antipsychotic Agents; Binding Sites; Cell Line; CHO Cells; Cricetinae; Cricetulus; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Molecular Targeted Therapy; Muscle Contraction; Muscle, Smooth; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction	2011

Article

Year

Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.

The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:3

Topics: Animals; Antipsychotic Agents; Binding Sites; Cell Line; CHO Cells; Cricetinae; Cricetulus; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Molecular Targeted Therapy; Muscle Contraction; Muscle, Smooth; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction

2011